Calcium channel blocker toxicity represents a significant clinical challenge owing to its multifaceted pathophysiology and potential to precipitate life‐threatening cardiovascular compromise. Overdose ...

Toxicity due to calcium-channel blockers (CCBs) or β-blockers results in significant morbidity and mortality. [9] The manifestations of toxicity are generally extensions of the drugs' pharmacologic ...

NEW YORK, July 31 (Praxis Press) Cardiovascular outcomes have not been compared in hypertensive patients treated with calcium channel blockers and in patients treated with older drugs. Hansson and ...

When you have atrial fibrillation, the two upper chambers of your heart (atria) don't beat in sync with the two lower chambers (ventricles). This makes your heart beat out of rhythm and sometimes very ...

A woman with hopes to conceive was diagnosed with severe vasospastic angina (VSA); however, she was able to carry a healthy baby to full term without angina attacks after starting treatment of a ...

Findings provide reassurance to physicians and patients about the long-term safety of dihydropyridine calcium channel blockers in the treatment of pancreatic cancer. This was a new user, active ...

Cardioselective beta-blockers act on beta-1 more than beta-2 and thus will not trigger or worsen asthma as much as non-cardioselective beta-blockers. Carvedilol and labetalol are non-selective ...

A systematic review evaluated the efficacy of calcium channel blockers or alpha blockers for the treatment of urinary stones in nine randomized trials with 693 patients (Lancet. 2006;368:1171-1179).

Use of calcium channel blockers (CCBs), particularly cardioselective agents, had a modest but statistically significant association with glaucoma, a large meta-analysis showed. Overall, patients with ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...